Filing Details

Accession Number:
0001181431-12-039366
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-07-03 16:02:58
Reporting Period:
2012-07-02
Filing Date:
2012-07-03
Accepted Time:
2012-07-03 16:02:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1001233 Sangamo Biosciences Inc SGMO Biological Products, (No Disgnostic Substances) (2836) 680359556
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1234387 William John Larson C/O Sangamo Biosciences Inc.
Point Richmond Tech Cntr, 501 Canal Blvd
Richmond CA 94804
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-07-02 1,541 $5.20 296,619 No 4 S Direct
Common Stock Disposition 2012-07-02 200 $5.20 296,419 No 4 S Direct
Common Stock Disposition 2012-07-02 100 $5.21 296,319 No 4 S Direct
Common Stock Disposition 2012-07-02 400 $5.21 295,919 No 4 S Direct
Common Stock Disposition 2012-07-02 100 $5.22 295,819 No 4 S Direct
Common Stock Disposition 2012-07-02 1,473 $5.22 294,346 No 4 S Direct
Common Stock Disposition 2012-07-02 100 $5.22 294,246 No 4 S Direct
Common Stock Disposition 2012-07-02 1,927 $5.23 292,319 No 4 S Direct
Common Stock Disposition 2012-07-02 100 $5.23 292,219 No 4 S Direct
Common Stock Disposition 2012-07-02 100 $5.24 292,119 No 4 S Direct
Common Stock Disposition 2012-07-02 4,100 $5.24 288,019 No 4 S Direct
Common Stock Disposition 2012-07-02 1,600 $5.25 286,419 No 4 S Direct
Common Stock Disposition 2012-07-02 2,500 $5.26 283,919 No 4 S Direct
Common Stock Disposition 2012-07-02 359 $5.27 283,560 No 4 S Direct
Common Stock Disposition 2012-07-02 100 $5.28 283,460 No 4 S Direct
Common Stock Disposition 2012-07-02 300 $5.29 283,160 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to the Rule 10b5-1 trading plan adopted by the Reporting Person on March 30, 2012.